Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lundbeck

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lundbeck's 2013 CNS (central nervous system) sales performance.

Lundbeck bolts on migraine drug via $1.95bn deal to buy Alder

Lundbeck bolts on migraine drug via $1.95bn deal to buy Alder

Lundbeck clearly agrees, saying the drug provides “immediate and complete bioavailability with high specificity and strong binding for suppression of…CGRP”. ... Deborah Dunsire, CEO, Lundbeck. Dunsire said Alder is “an excellent strategic fit for

Lundbeck’s key products shine in Q2 but problems remain

Lundbeck’s key products shine in Q2 but problems remain Sales of the four key products accounted for more than half of Lundbeck’s sales in the quarter. ... Following the Abide Therapeutics acquisition in 2Q19, Lundbeck's total deal capacity is around $4bn-5bn.

Lundbeck snaps up Abide Therapeutics for $400m

Lundbeck snaps up Abide Therapeutics for $400m Also acquires its lead drug for Tourette’s syndrome. Danish drugmaker Lundbeck has moved to bolster its pipeline with a $400m deal to acquire Abide Therapeutics and its lead drug for ... Lundbeck said that the deal will be financed using existing cash

AZ’s Sean Bohen to exit after business overhaul; report

AZ’s Sean Bohen to exit after business overhaul; report Pascal Soriot, CEO, AZ. In the end Teva poached Lundbeck CEO Kåre Schultz to fill its top job, but the rumours keep resurfacing with The Times suggesting last November that AZ

Is AstraZeneca looking for its next CEO?

Is AstraZeneca looking for its next CEO? However, he eventually distanced himself from the idea, and the hot seat at the debt-burdened Israel-headquartered company went to Lundbeck’s chief Kåre Schultz instead.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics